MedLabs Diagnostics announced the completion of its recapitalization led by its management, Caymus Equity Partners and PNC Mezzanine Capital.
Headquartered in Cedar Knolls, NJ, MedLabs Diagnostics is one of the oldest, independent reference laboratories in the United States.
The company provides a large, comprehensive menu of laboratory-developed, esoteric, STAT and routine tests.
The transaction provides MedLabs with the necessary capital and resources to further grow its business through the expansion of its proprietary product portfolio in its existing and new geographic territories as well as future add-on acquisitions.
MedLabs also intends to roll out new technology platforms and tools for its existing client base to further increase the impact a laboratory can have on patient outcomes in today’s value-based healthcare market.
MedLabs, already one of the fastest growing independent clinical diagnostic laboratories, expects that this investment will fuel years of continued growth and innovation
Crosstree Capital Partners acted as exclusive financial advisor to MedLabs Diagnostics.
Crosstree ran a thorough, competitive sale process, exploring an array of financial and strategic alternatives for MedLabs’ ownership.
The transaction achieves the owners’ goals of balancing current liquidity with a desire to preserve family ownership and continued independent, quality operations.